Package Leaflet:information for the patient
Bilastina pensa 20 mg tablets EFG
Read the entire package leaflet carefully before starting to take this medication,as it contains important information for you.
Contents of the package leaflet
5 Conservation of Bilastina pensa
This medication contains bilastina as the active ingredient, which is an antihistamine.
Bilastina is used to relieve the symptoms of allergic rhinoconjunctivitis (sneezing, nasal itching, nasal discharge, nasal congestion, and red and watery eyes) and other forms of allergic rhinitis. It may also be used to treat skin eruptions with itching (hives or urticaria).
Do not take Bilastina pensa
Warnings and precautions
Consult your doctor or pharmacist before starting to take bilastina if you have moderate or severe renal insufficiency and are also taking other medications (see "Other medications and Bilastina pensa").
Children
Do not administer this medication to children under 12 years of age.
Do notexceed the recommended dose. If symptoms persist, consult your doctor.
Other medications and Bilastina pensa
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including those purchased without a prescription.
In particular, please discuss with your doctor if you are taking any of the following medications:
Taking Bilastina pensa with food, beverages, and alcohol
These tabletsshould notbe taken withfoodor withgrapefruit juice or other fruit juices, as this would decrease the effect of bilastina. To avoid this, you can:
Bilastina, at the recommended dose (20 mg), does not increase the drowsiness caused by alcohol.
Pregnancy, breastfeeding, and fertility
There are no data or limited data on the use of bilastina in pregnant women, during the lactation period, or on its effects on fertility.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before taking this medication.
Consult your doctor or pharmacist before using any medication.
Driving and using machines
It has been shown that bilastina 20 mg does not affect performance during driving in adults. However, each patient's response to the medication may be different. Therefore, check how this medication affects you before driving or using machines.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose in adults, including elderly patients and adolescents 12 years of age or older, is 1 tablet (20 mg) per day.
Regarding the duration of treatment, your doctor will determine the type of disease you have and indicate how long you should take Bilastina pensa.
Use in children
For children 6 to 11 years of age with a minimum body weight of 20 kg, there are other pharmaceutical forms more suitable – bilastina 10 mg orodispersible tablets or bilastina 2.5 mg/ml oral solution. Consult your doctor or pharmacist.
Do not administer this medication to children under 6 years of age with a body weight below 20 kg, as there are insufficient data available.
If you take more Bilastina pensa than you should
If you or anyone else takes more of this medication than they should, inform your doctor or pharmacist immediately or go to the emergency department of the nearest hospital. Please remember to bring this medication packaging or this package leaflet with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20 (indicating the medication and the amount ingested).
If you forget to take Bilastina pensa
Do nottake a double dose to make up for a forgotten dose.
If you forget to take your dose, take it as soon as possible, and then return to your regular dosing schedule.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Side effects that may occur in adults and adolescents are:
Frequent: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Frequency not known: cannot be estimated from available data:
Side effects that may occur in children:
Frequent: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and blister after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the pharmacy's SIGRE point. If you are unsure, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Bilastina pensa
Appearance of the product and contents of the packaging
The Bilastina pensa tablets are round and white.
They are available in packs of 20 tablets.
Marketing authorization holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
Noucor Health, S.A.
Avda. Camí Reial, 51-57
08184 Palau-solità i Plegamans
Barcelona, Spain
This medication is authorized in the Member States of the European Economic Area under the following names:
Spain: Bilastina pensa 20 mg tablets EFG
Portugal: Bilastina Tolife
Italy: Bilastina pensa
Date of the last revision of thispackage leaflet: July 2021
Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
The average price of BILASTINA PENSA 20 mg TABLETS in October, 2025 is around 5.82 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.